Friday, June 8, 2018

Aphria News: "we are ready to serve the recreational adult use market and meet the needs of Canadians"

We are ready to serve the recreational adult use market and meet the needs of Canadians. 

Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada

Canada NewsWire
LEAMINGTON, ONJune 8, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today provided the following statement in reaction to the passage of Bill C-45, the Cannabis Act, in the Senate of Canada:  
Vic Neufeld, CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada. We applaud the government's drive to establish a rational regulatory framework for adult-use cannabis that is designed to protect public health and safety, restrict access to youth, and eliminate the black market. It is a significant day that further cements Canada as the preeminent leader in the global cannabis sector."
"While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations. To do this, we believe that is critical that licensed producers be allowed to use limited forms of adult focused branding to properly educate Canadians about the differences between illegal and legal products. We also continue to advocate to exempt medicinal cannabis from excise taxes to ensure that it is subject to the same considerations as other medications. We encourage government to consider these changes as Bill C-45 passes through the final stages of legalization."
"As Canada moves one step closer to adult-use cannabis legalization, 

Aphria is well positioned as a global leader in the exciting cannabis market. With growing production capacity, innovative products, R&D expertise as well as talented and experienced people, we are ready to serve the recreational adult use market and meet the needs of Canadians. We look forward to working with government as a long-term partner to continue to position Canada as global success story," added Mr. Neufeld.

About Aphria
Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.
For more information, visit: aphria.ca

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations with respect to actual production volumes, expectations for future growing capacity and costs, the completion of any capital project or expansions, and expectations with respect to future production costs. 

Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Aphria Inc.

APH Anon Biggest Seller Again Hammering APH Net Gain $7,425,427

1 Anonymous1,500,43217,637,40011.7552,124,99225,062,82711.794-624,560$7,425,427


House Positions for C:APH from 20180608 to 20180608
HouseBought$ValAveSold$ValAveNet$Net
1 Anonymous1,500,43217,637,40011.7552,124,99225,062,82711.794-624,5607,425,427
79 CIBC1,220,11814,360,83511.771,486,41717,520,64611.787-266,2993,159,811
53 Morgan Stanley39,255465,80111.86695,3801,112,42411.663-56,125646,623
76 Industrial Alliance047,500551,03211.601-47,500551,032
43 Caldwell040,000470,02311.751-40,000470,023
15 UBS3,71643,70511.76133,910396,06311.68-30,194352,358
65 Goldman4004,78911.97313,300154,49711.616-12,900149,708
36 Latimer6,52976,76111.7578,40098,75511.757-1,87121,994
3 AltaCorp1,50017,77011.8471,50017,88511.9230115
68 Leede1,00011,92011.921,00011,98011.98060
62 Haywood3,60042,33611.763,60042,94811.930612
70 Manulife5806,77311.6785005,78011.5680-993
25 Odlum2002,36211.810200-2,362
48 Laurentian5005,87011.740500-5,870
99 Jitney116,2001,367,95711.772115,6001,362,25811.784600-5,699
22 Fidelity38,224451,72311.81837,514442,14111.786710-9,582
56 Edward Jones1,20014,19211.82701,200-14,192
88 Credential1,80621,50311.9064104,73811.5561,396-16,765
90 Barclays4,40051,83511.7814046911.7254,360-51,366
28 BBS8,48599,13011.6833,73043,35111.6224,755-55,779
57 Interactive6,79979,98211.7641,85121,79811.7764,948-58,184
89 Raymond James5,25061,31011.67805,250-61,310
14 ITG16,719197,24311.79810,350122,48611.8346,369-74,757
39 Merrill Lynch234,2362,778,90711.864227,4922,668,07211.7286,744-110,835
83 Mackie10,000115,99811.60010,000-115,998
58 Qtrade17,510206,59611.7997,04583,15911.80410,465-123,437
72 Credit Suisse12,294145,38711.8262002,35211.7612,094-143,035
74 GMP13,595161,10011.855005,90011.8013,095-155,200
19 Desjardins63,261746,33911.79845,036530,78411.78618,225-215,555
33 Canaccord266,6453,144,93811.794247,3002,917,77111.79919,345-227,167
143 Pershing46,551550,87611.83417,190202,95111.80629,361-347,925
59 PI36,350422,84211.6333,11236,54911.74533,238-386,293
124 Questrade162,8781,916,36711.766119,9251,409,18811.75142,953-507,179
80 National Bank183,8612,165,73911.779113,2871,328,65911.72870,574-837,080
13 Instinet233,2192,751,18711.797157,0791,835,87011.68876,140-915,317
85 Scotia456,2085,382,83511.799316,7093,714,54511.729139,499-1,668,290
7 TD Sec855,35210,061,65911.763712,9668,391,83111.77142,386-1,669,828
2 RBC454,2975,338,96811.752243,7902,868,33911.766210,507-2,470,629
9 BMO Nesbitt310,0423,650,53411.77495,5871,123,39811.753214,455-2,527,136
TOTAL6,333,21274,561,46911.7736,333,21274,561,46911.77300

Search The Web